We are a clinical stage biopharmaceutical company focused on utilizing our genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets.
Lead Underwriter
Joseph Gunnar and Co., L.L.C ,Rodman & Renshaw a unit of H.C. Wainwright & Co., LLC
